ALLIX Fundamental Analysis - WALLIX GROUP

Fundamental Rating

Overall ALLIX gets a fundamental rating of 2 out of 10. We evaluated ALLIX against 125 industry peers in the Software industry. Both the profitability and financial health of ALLIX have multiple concerns. While showing a medium growth rate, ALLIX is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALLIX had negative earnings in the past year.
ALLIX had a positive operating cash flow in the past year.
In the past 5 years ALLIX always reported negative net income.
In multiple years ALLIX reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.54%, ALLIX is doing worse than 66.40% of the companies in the same industry.
ALLIX's Return On Equity of -24.53% is on the low side compared to the rest of the industry. ALLIX is outperformed by 76.80% of its industry peers.

		Industry Rank	Sector Rank
ROA	-3.54%
ROE	-24.53%
ROIC	N/A

ROA(3y)-11.42%

ROA(5y)-10.74%

ROE(3y)-44.79%

ROE(5y)-35.26%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALLIX has a better Gross Margin (114.69%) than 100.00% of its industry peers.
ALLIX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	114.69%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.14%

GM growth 5Y-0.06%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALLIX has a better debt/assets ratio than last year.

2.2 Solvency

ALLIX has an Altman-Z score of 1.63. This is a bad value and indicates that ALLIX is not financially healthy and even has some risk of bankruptcy.
ALLIX has a Altman-Z score of 1.63. This is in the lower half of the industry: ALLIX underperforms 64.80% of its industry peers.
A Debt/Equity ratio of 1.07 is on the high side and indicates that ALLIX has dependencies on debt financing.
ALLIX has a Debt to Equity ratio of 1.07. This is amonst the worse of the industry: ALLIX underperforms 81.60% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	N/A
Altman-Z	1.63

ROIC/WACCN/A

WACC8.66%

2.3 Liquidity

A Current Ratio of 0.81 indicates that ALLIX may have some problems paying its short term obligations.
The Current ratio of ALLIX (0.81) is worse than 88.00% of its industry peers.
A Quick Ratio of 0.81 indicates that ALLIX may have some problems paying its short term obligations.
ALLIX has a Quick ratio of 0.81. This is amonst the worse of the industry: ALLIX underperforms 85.60% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.81
Quick Ratio	0.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.48% over the past year.
Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 17.72% in the last year.
The Revenue has been growing by 15.85% on average over the past years. This is quite good.

EPS 1Y (TTM)79.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%46.55%

Revenue 1Y (TTM)17.72%

Revenue growth 3Y13.73%

Revenue growth 5Y15.85%

Sales Q2Q%18.89%

3.2 Future

The Earnings Per Share is expected to grow by 63.49% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALLIX will show a very strong growth in Revenue. The Revenue will grow by 22.11% on average per year.

EPS Next Y103.9%

EPS Next 2Y75.44%

EPS Next 3Y63.49%

EPS Next 5YN/A

Revenue Next Year21.15%

Revenue Next 2Y21.78%

Revenue Next 3Y22.11%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALLIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 32.28, ALLIX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALLIX is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 24.31. ALLIX is valued slightly more expensive when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	32.28

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALLIX indicates a slightly more expensive valuation: ALLIX is more expensive than 60.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	57.46

4.3 Compensation for Growth

ALLIX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALLIX's earnings are expected to grow with 63.49% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y75.44%

EPS Next 3Y63.49%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALLIX!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

WALLIX GROUP

EPA:ALLIX (1/15/2026, 7:00:00 PM)

27.6

+0.3 (+1.1%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)11-03 2025-11-03

Earnings (Next)03-18 2026-03-18/amc

Inst Owners10.59%

Inst Owner ChangeN/A

Ins Owners19.72%

Ins Owner ChangeN/A

Market Cap186.02M

Revenue(TTM)36.95M

Net Income(TTM)-1.80M

Analysts84

Price Target31.11 (12.72%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)35.56%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-50%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	32.28
P/S	5.03
P/FCF	N/A
P/OCF	45.03
P/B	25.37
P/tB	N/A
EV/EBITDA	57.46

EPS(TTM)-0.28

EYN/A

EPS(NY)0.85

Fwd EY3.1%

FCF(TTM)-0.42

FCFYN/A

OCF(TTM)0.61

OCFY2.22%

SpS5.48

BVpS1.09

TBVpS-1.98

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.54%
ROE	-24.53%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	114.69%
FCFM	N/A

ROA(3y)-11.42%

ROA(5y)-10.74%

ROE(3y)-44.79%

ROE(5y)-35.26%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.14%

GM growth 5Y-0.06%

F-Score6

Asset Turnover0.73

Health

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	N/A
Debt/EBITDA	2.36
Cap/Depr	121.53%
Cap/Sales	18.87%
Interest Coverage	N/A
Cash Conversion	124.2%
Profit Quality	N/A
Current Ratio	0.81
Quick Ratio	0.81
Altman-Z	1.63

F-Score6

WACC8.66%

ROIC/WACCN/A

Cap/Depr(3y)134.63%

Cap/Depr(5y)153.59%

Cap/Sales(3y)19.11%

Cap/Sales(5y)22.25%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)79.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%46.55%

EPS Next Y103.9%

EPS Next 2Y75.44%

EPS Next 3Y63.49%

EPS Next 5YN/A

Revenue 1Y (TTM)17.72%

Revenue growth 3Y13.73%

Revenue growth 5Y15.85%

Sales Q2Q%18.89%

Revenue Next Year21.15%

Revenue Next 2Y21.78%

Revenue Next 3Y22.11%

Revenue Next 5YN/A

EBIT growth 1Y75.02%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year144.36%

EBIT Next 3Y66.73%

EBIT Next 5YN/A

FCF growth 1Y50.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y549.02%

OCF growth 3Y-37.14%

OCF growth 5YN/A

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALLIX.PA.

What is the valuation status for ALLIX stock?

ChartMill assigns a valuation rating of 2 / 10 to WALLIX GROUP (ALLIX.PA). This can be considered as Overvalued.

What is the profitability of ALLIX stock?

WALLIX GROUP (ALLIX.PA) has a profitability rating of 2 / 10.

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

What is the valuation status for ALLIX stock?

What is the profitability of ALLIX stock?